(en) Helen J. Knowles, Ya-Min Tian, David R. Mole et Adrian L. Harris, « Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases », Circulation Research, vol. 95, no 2, , p. 162-169 (PMID15192023, DOI10.1161/01.RES.0000134924.89412.70, lire en ligne)
doi.org
dx.doi.org
(en) Bernard Bourreli, Michel Pinaud, Norbert Passuti, Jean-Pierre Gunst, Jean-Christophe Drouet et Jean-Pierre Remi, « Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion », Canadian Journal of Anaesthesia, vol. 35, no 3, , p. 242-248 (PMID3383316, DOI10.1007/BF03010617, lire en ligne)
(en) Myrna Candelaria, Aquileo Herrera, Juan Labardini, Aurora González-Fierro, Catalina Trejo-Becerril, Lucía Taja-Chayeb, Enrique Pérez-Cárdenas, Erick de la Cruz-Hernández, Daymi Arias-Bofill, Silvia Vidal, Eduardo Cervera et Alfonso Dueñas-Gonzalez, « Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial », Annals of Hematology, vol. 90, no 4, , p. 379-387 (PMID20922525, DOI10.1007/s00277-010-1090-2, lire en ligne)
(en) Helen J. Knowles, Ya-Min Tian, David R. Mole et Adrian L. Harris, « Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases », Circulation Research, vol. 95, no 2, , p. 162-169 (PMID15192023, DOI10.1161/01.RES.0000134924.89412.70, lire en ligne)
(en) Bernard Bourreli, Michel Pinaud, Norbert Passuti, Jean-Pierre Gunst, Jean-Christophe Drouet et Jean-Pierre Remi, « Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion », Canadian Journal of Anaesthesia, vol. 35, no 3, , p. 242-248 (PMID3383316, DOI10.1007/BF03010617, lire en ligne)
(en) Myrna Candelaria, Aquileo Herrera, Juan Labardini, Aurora González-Fierro, Catalina Trejo-Becerril, Lucía Taja-Chayeb, Enrique Pérez-Cárdenas, Erick de la Cruz-Hernández, Daymi Arias-Bofill, Silvia Vidal, Eduardo Cervera et Alfonso Dueñas-Gonzalez, « Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial », Annals of Hematology, vol. 90, no 4, , p. 379-387 (PMID20922525, DOI10.1007/s00277-010-1090-2, lire en ligne)
(en) Helen J. Knowles, Ya-Min Tian, David R. Mole et Adrian L. Harris, « Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases », Circulation Research, vol. 95, no 2, , p. 162-169 (PMID15192023, DOI10.1161/01.RES.0000134924.89412.70, lire en ligne)
(en) Bernard Bourreli, Michel Pinaud, Norbert Passuti, Jean-Pierre Gunst, Jean-Christophe Drouet et Jean-Pierre Remi, « Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion », Canadian Journal of Anaesthesia, vol. 35, no 3, , p. 242-248 (PMID3383316, DOI10.1007/BF03010617, lire en ligne)
(en) Myrna Candelaria, Aquileo Herrera, Juan Labardini, Aurora González-Fierro, Catalina Trejo-Becerril, Lucía Taja-Chayeb, Enrique Pérez-Cárdenas, Erick de la Cruz-Hernández, Daymi Arias-Bofill, Silvia Vidal, Eduardo Cervera et Alfonso Dueñas-Gonzalez, « Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial », Annals of Hematology, vol. 90, no 4, , p. 379-387 (PMID20922525, DOI10.1007/s00277-010-1090-2, lire en ligne)
